Results 221 to 230 of about 148,871 (301)

Multiple‐Dose Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Subcutaneous Rusfertide, a Hepcidin Mimetic, in Healthy Subjects

open access: yesClinical Pharmacology in Drug Development, Volume 14, Issue 4, Page 311-323, April 2025.
Abstract Rusfertide, a peptide hepcidin mimetic, has shown efficacy in polycythemia vera. This trial investigated the multiple‐dose pharmacokinetics, pharmacodynamics, and safety of once‐weekly rusfertide 60 mg for 5 weeks in healthy subjects. Subjects were randomized to subcutaneous injection in the abdomen, upper arm, or thigh. Eighteen subjects were
Nishit B. Modi   +2 more
wiley   +1 more source

Transparency, Resiliency, and Sustainable Supply Chain Network Design by Considering New Technology

open access: yesEngineering Reports, Volume 7, Issue 4, April 2025.
This research proposes a new Supply Chain Network Design (SCND) model using emerging technologies. It aims to reduce costs while improving sustainability, flexibility, and transparency. A probabilistic optimization approach is employed, resulting in a 0.1% cost reduction.
Mansour Bazregar   +2 more
wiley   +1 more source

Prerequisites for Clinical Implementation of Whole‐Heart 4D‐Flow MRI: A Delphi Analysis

open access: yesJournal of Magnetic Resonance Imaging, Volume 61, Issue 4, Page 1618-1628, April 2025.
Whole‐heart 4D‐flow MRI is a valuable tool for advanced visualization and quantification of blood flow in cardiovascular imaging. Despite advantages over 2D‐phase‐contrast flow, clinical implementation remains only partially exploited due to many hurdles in all steps, from image acquisition, reconstruction, postprocessing and analysis, clinical ...
Joost van Schuppen   +13 more
wiley   +1 more source

Targeting MDA‐MB‐231 Cancer Stem Cells With Temsirolimus in 3D Collagen/PGA/Na2SiO3‐Based Bone Model

open access: yesMacromolecular Materials and Engineering, Volume 310, Issue 4, April 2025.
The efficacy of the mTORC1 inhibitor temsirolimus is assessed on CD44+/CD24‐ CSCs from MDA‐MB‐231, using a 3D bone‐like model with a PLA scaffold. Osteogenic differentiation of BM‐MSCs and CSC invasion are induced. After applying IC50 = 5 µM for 6 hours, mTOR protein levels are evaluated, stemness, epthelial‐mesenchymal transition (EMT), and drug ...
Özlem Altundag‐Erdogan   +3 more
wiley   +1 more source

Harnessing ChatGPT for Thematic Analysis: Are We Ready?

open access: yesJ Med Internet Res
Lee VV   +3 more
europepmc   +1 more source

PanKB: An interactive microbial pangenome knowledgebase for research, biotechnological innovation, and knowledge mining. [PDF]

open access: yesNucleic Acids Res
Sun B   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy